TNFSF10 and neoplasm: PI-103 and 17-AAG both decreased AKTSer473 phosphorylation when used as single agents in RKO tumor cells; moreover, when combined with TRAIL they prevented the increase in phospho-AKT caused by the ligand alone (Fig. 5B).